EnfiniT platform for CAR-T

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark EnfiniT platform for CAR-T was filed as Word mark on 09/14/2021 at the World Intellectual Property Organization.

Trademark Details Last update: August 9, 2023

Trademark form Word mark
File reference 1638160
Countries Australia Brazil Canada European Community United Kingdom India Japan New Zealand United States of America (USA) China Russia
Base trademark FR No. 4770321, May 26, 2021
Application date September 14, 2021
Expiration date September 14, 2031

Trademark owner

7-11 boulevard Haussmann
F-75009 Paris
FR

Trademark representatives

goods and services

01 Biological and chemical products for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions
05 Pharmaceutical products; biological and pharmaceutical preparations; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic solutions, namely, antigen, antibodies, T-cells; biological materials, preparations, reagents for medical products; antigens, antibodies, cells for therapeutic use
40 Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; manufacturing antigens, antibodies, T-cells; providing information in the field of manufacturing pharmaceuticals
42 Scientific research services for medical purposes; identifying, screening and developing antigens; scientific and technological services; scientific laboratory services; providing scientific and medical information on immunotherapy; providing services for identifying, analyzng, authenticating, purifying and developing biological material from a genomic platform; epigenetic antigen screening and identification services for therapeutic research purposes; genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses
44 Providing medical information relating to immunotherapy

Trademark history

Date Document number Area Entry
July 24, 2023 2023/32 Gaz CN Rejection
June 29, 2023 2023/27 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 16, 2023 2023/20 Gaz AU Rejection
May 5, 2023 2023/19 Gaz CA Rejection
April 28, 2023 2023/18 Gaz NZ RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 15, 2022 2022/51 Gaz JP Rejection
November 9, 2022 2022/45 Gaz BR Rejection
October 29, 2022 2022/44 Gaz RU RAW: Rule 18ter(2)(i) GP following a provisional refusal
July 6, 2022 2022/27 Gaz US Rejection
June 3, 2022 2022/23 Gaz RU Rejection
June 2, 2022 2022/24 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
May 26, 2022 2022/21 Gaz EM Rejection
May 15, 2022 2022/21 Gaz NZ Rejection
May 11, 2022 2022/20 Gaz RAW: Limitation
May 9, 2022 2022/19 Gaz CN Rejection
April 18, 2022 2022/16 Gaz GB Rejection
January 24, 2022 2022/5 Gaz IN Rejection
January 20, 2022 2022/3 Gaz AU Rejection
January 10, 2022 Correction
September 14, 2021 FR Registration

ID: 141638160